Track topics on Twitter Track topics that are important to you
Thomas Russo has left Gilead Sciences (NASDAQ: GILD) to become chief financial officer of Assembly Biosciences (NASDAQ: ASMB). Russo held a number of positions during his seven years at Gilead, and was most recently vice president and head of commercial finance. His experience also includes posts at Robert W. Baird & Co. and Merck (NYSE: […]
Original Article: Assembly Bio Taps Gilead’s Thomas Russo as Chief Financial OfficerNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...